Don’t Miss the signs
Freelite®
takes you in a new direction. The right one.
Polyclonal serum free light chain assays (Freelite) can be used in combination with serum protein electrophoresis as an efficient, proven diagnostic screen for monoclonal gammopathies,1 Working Group Guidelines.2
as recommended by International Myeloma
Include this simple blood test for free kappa and free lambda light chains in your initial screening algorithm and take a more direct route to diagnosis of Myeloma and related disorders.
Email
freelite@bindingsite.co.uk for your free copy of the guidelines.
Visit
www.bindingsite.com or MEDICA Hall 3, B73.
Follow the experts - use Freelite. 1. Katzmann JA, et al. Clin Chem2009; 55:1517-1522 2. Dispenzieri A, et
al.International Myeloma Working Group Guidelines Leukemia2009; 23:215-224
In Europe and the USA Freelite® is a registered trademark of The Binding Site Group Ltd, Birmingham, UK. The Binding Site Group Ltd Tel: +44 (0)121 456 9500 •
info@bindingsite.co.uk •
www.bindingsite.com The Specialist Protein Company
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40